| The Numbers... 
 THERMACELL TECHNOLOGIES, INC. and SUBSIDIARIES
 CONSOLIDATED STATEMENTS OF OPERATIONS
 (Unaudited)
 
 Three Months Ended      Nine Months Ended
 -------------------     ------------------
 -------------------     ------------------
 June 30,               June 30,
 -------------------     ------------------
 -------------------     ------------------
 1999       1998          1999          1998
 ----       ----          ----          ----
 Sales              $1,310,625     $789,183    $3,250,976    $2,259,814
 Cost of Sales         922,980      497,462     2,274,825     1,464,318
 ---------    ---------     ---------     ---------
 
 Gross Profit          387,645      291,721       976,151       795,496
 Selling, General
 & Admin Expenses     624,738      430,055     1,810,052     1,178,124
 ---------    ---------     ---------     ---------
 
 Loss from Operations (237,093)    (138,334)     (833,901)     (382,628)
 Other income
 (expense)           (19,430)      19,773       (24,463)       84,685
 ---------     ---------     ---------     ---------
 
 Loss Before
 Income Taxes       (256,523)    (118,561)     (858,364)     (297,943)
 Deferred Income
 Tax Benefit          51,305       23,712       171,672        59,589
 ---------     ---------     ---------     ---------
 
 Net Loss            ($205,218)    ($94,849)    ($686,692)    ($238,354)
 =========      =========    =========     =========
 Basic Loss per
 Common Share         ($0.02)      ($0.03)       ($0.09)       ($0.08)
 =========      =========    =========     =========
 Weighted Average
 Common Shares
 Outstanding       8,698,238    4,153,620     7,575,889     3,432,484
 =========    =========     =========     =========
 
 Forward Looking Statements: This news release contains certain ''forward-looking'' statements within the meaning of the
 Private Securities Litigation Reform Act of 1995, which provides a new ''safe harbor'' for these types of statements. To the extent statements in this news release involve, without limitation, product development and introduction plans, the Company's expectations for growth, estimates of future revenue, expenses, profit, cash flow, balance sheet items, sell-through or backlog, forecasts of demand or market trends for the Company's product categories and for the industries in which the Company operates, or any other guidance on future periods, these statements are forward-looking statements. The Company assumes no obligation to update forward-looking statements. ----------------------------------------------------------------------
 
 Contact:
 
 Thermacell Technologies
 Gary Fishman
 or
 Kimberly Ferro
 212-889-1727
 |